CD8A and neoplasm: ATO/PpIX-PDT plus Anti-PD-L1 can improve tumor hypoxic immunosuppressive microenvironment and inhibit tumor growth; CD80+CD86+↑; TNF-α, IFN-γ, IL-12 ↑; CD8+ T cells ↑;